Name | Number of supported studies | Average coverage | |
---|---|---|---|
type II pneumocyte | 10 studies | 45% ± 21% | |
type I pneumocyte | 7 studies | 22% ± 8% | |
squamous epithelial cell | 4 studies | 31% ± 25% | |
basal cell | 4 studies | 24% ± 6% | |
epithelial cell | 3 studies | 27% ± 15% | |
club cell | 3 studies | 29% ± 10% | |
ciliated cell | 3 studies | 27% ± 3% |
Insufficient scRNA-seq data for expression of SDR16C5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 85% | 3701.23 | 490 / 578 | 83% | 39.88 | 955 / 1155 |
esophagus | 39% | 1602.56 | 558 / 1445 | 76% | 24.26 | 139 / 183 |
tonsil | 0% | 0 | 0 / 0 | 93% | 56.27 | 42 / 45 |
stomach | 29% | 215.16 | 103 / 359 | 54% | 12.72 | 155 / 286 |
pancreas | 0% | 0 | 0 / 328 | 79% | 34.62 | 141 / 178 |
skin | 72% | 3880.59 | 1298 / 1809 | 7% | 1.48 | 35 / 472 |
intestine | 9% | 60.39 | 90 / 966 | 64% | 19.14 | 337 / 527 |
breast | 9% | 51.84 | 43 / 459 | 62% | 20.44 | 692 / 1118 |
uterus | 1% | 52.14 | 2 / 170 | 62% | 23.76 | 285 / 459 |
bladder | 0% | 0 | 0 / 21 | 35% | 11.78 | 177 / 504 |
brain | 14% | 77.61 | 361 / 2642 | 4% | 0.30 | 28 / 705 |
lymph node | 0% | 0 | 0 / 0 | 14% | 2.79 | 4 / 29 |
adrenal gland | 0% | 0 | 0 / 258 | 9% | 1.16 | 20 / 230 |
ovary | 1% | 7.47 | 1 / 180 | 8% | 0.56 | 34 / 430 |
thymus | 0% | 0 | 0 / 653 | 8% | 0.69 | 47 / 605 |
prostate | 1% | 3.84 | 2 / 245 | 2% | 0.82 | 9 / 502 |
liver | 0% | 0 | 0 / 226 | 2% | 0.77 | 8 / 406 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.04 | 4 / 901 |
adipose | 0% | 6.54 | 5 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 1.91 | 2 / 929 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.28 | 1 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 1.73 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045814 | Biological process | negative regulation of gene expression, epigenetic |
GO_0042574 | Biological process | retinal metabolic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0043616 | Biological process | keratinocyte proliferation |
GO_0042572 | Biological process | retinol metabolic process |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0000785 | Cellular component | chromatin |
GO_0005886 | Cellular component | plasma membrane |
GO_0005811 | Cellular component | lipid droplet |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005634 | Cellular component | nucleus |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0004745 | Molecular function | all-trans-retinol dehydrogenase (NAD+) activity |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SDR16C5 |
Protein name | Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5) Retinal short chain dehydrogenase reductase isoform 1, isoform CRA_c (Short chain dehydrogenase/reductase family 16C member 5) |
Synonyms | hCG_1787435 RDHE2 |
Description | FUNCTION: Oxidoreductase with strong preference for NAD . Active in both the oxidative and reductive directions . Oxidizes all-trans-retinol in all-trans-retinaldehyde . No activity was detected with 11-cis-retinol or 11-cis-retinaldehyde as substrates with either NAD(+)/NADH or NADP(+)/NADPH . . |
Accessions | Q8N3Y7 ENST00000522671.1 ENST00000396721.6 [Q8N3Y7-2] G3V145 ENST00000303749.8 [Q8N3Y7-1] |